This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, H. Articles by Young, D. B. Search for Related Content PubMed PubMed Citation Articles by Lin, H. Articles by Young, D. B.

(Circulation. 1995;91:1135-1142.)
© 1995 American Heart Association, Inc.

Articles

Opposing Effects of Plasma Epinephrine and Norepinephrine on Coronary Thrombosis In Vivo

Huabao Lin, PhD; David B. Young, PhD

Correspondence to Huabao Lin, PhD, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505.

Background It is well known that plasma catecholamines and myocardial infarction have a close relation and that coronary artery thrombosis is a major cause of myocardial infarction. In addition, epinephrine is known to be a prothrombogenic agent in vivo. However, the role of the other major circulating catecholamine, norepinephrine, in the development of coronary thrombosis is somewhat uncertain, although the role of norepinephrine is often considered analogous to the role of epinephrine. Therefore, the present study was designed to investigate the effect of norepinephrine and its interaction with epinephrine on coronary thrombosis.

Methods and Results To compare the effects of epinephrine and norepinephrine on coronary thrombosis, we analyzed the frequency of cyclic blood flow reductions (CFRs) in an anesthetized canine model of coronary thrombosis (n=25). Three experiments were used in the present study. In the first experiment with epinephrine infusion, plasma epinephrine was elevated from 0.46±0.25 to 27.7±1.85 nmol/L. The frequency of CFRs increased by more than 60%, from 7.1±0.5 to 11.5±0.7 in 40 minutes (P<.01). The second experiment included three experimental periods: control, norepinephrine infusion, and norepinephrine infusion plus epinephrine infusion. Norepinephrine was infused to raise plasma norepinephrine from 1.3±0.2 to 32.4±4.3 nmol/L. The frequency of CFRs in the dogs was markedly reduced, from 7.89±0.42 to 2.41±1.08 in 40 minutes (P<.01), whereas arterial pressure was elevated from 88±3 to 118±5 mm Hg (P<.01). However, when epinephrine infusion was added to the norepinephrine infusion, the frequency of CFRs increased from 2.41±1.08 to 7.74±1.12 in 40 minutes (P<.01). In the third experiment, a servocontrol device was used during the norepinephrine infusion to prevent rises in coronary arterial pressure. As a result of the norepinephrine infusion, the frequency of CFRs was reduced from 7.47±0.71 to 0.83±0.65 in 40 minutes (P<.01), even though the coronary arterial pressure was not altered.

Conclusions The present study demonstrated that infusion of epinephrine stimulated coronary artery thrombosis, whereas infusion of norepinephrine inhibited coronary artery thrombosis. In addition, the inhibitory effect of norepinephrine on coronary thrombosis is independent of increases in coronary arterial pressure. Therefore, the present findings suggest that epinephrine and norepinephrine have opposing effects on coronary thrombosis in dogs.

Key Words: catecholamines • thrombosis • coronary disease • circulation • platelets

This article has been cited by other articles:

				C. B. Overgaard and V. Dzavik Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease Circulation, September 2, 2008; 118(10): 1047 - 1056. [Full Text] [PDF]

				Y. Gidron, H. Gilutz, R. Berger, and M. Huleihel Molecular and cellular interface between behavior and acute coronary syndromes Cardiovasc Res, October 1, 2002; 56(1): 15 - 21. [Abstract] [Full Text] [PDF]